Concert Pharma (CNCE) Misses Q1 EPS by 18c

Concert Pharma (NASDAQ: CNCE) reported Q1 EPS of ($0.63), $0.18 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Viking Holdings (VIK) PT Raised to $121 at UBS Ahead of Q2 Earnings
• Truist's 2Q26 Off-Cycle Earnings Preview for Cybersecurity Software: 'We favor RBRK and SAIL'